SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-21-201893
Filing Date
2021-06-28
Accepted
2021-06-28 16:01:34
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-1 d166948ds1.htm S-1 979709
2 EX-1.1 d166948dex11.htm EX-1.1 223937
3 EX-5.1 d166948dex51.htm EX-5.1 11479
4 EX-10.15 d166948dex1015.htm EX-10.15 38967
5 EX-23.1 d166948dex231.htm EX-23.1 1624
6 GRAPHIC g166948g01s66.jpg GRAPHIC 66200
7 GRAPHIC g166948g05g35.jpg GRAPHIC 2396
8 GRAPHIC g166948g08s10.jpg GRAPHIC 126340
9 GRAPHIC g166948g39n27.jpg GRAPHIC 3882
10 GRAPHIC g166948g55a77.jpg GRAPHIC 218272
  Complete submission text file 0001193125-21-201893.txt   1818019
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-257466 | Film No.: 211053290
SIC: 2836 Biological Products, (No Diagnostic Substances)